Skip to main content
Log in

Determination of EGFR gene somatic mutations in tissues and plasma of patients with non-small cell lung cancer

Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry Aims and scope Submit manuscript

Abstract

Activating mutations in the EGFR gene influence cell proliferation, angiogenesis, and increases metastatic ability of non-small cell lung cancer (NSCLC) cells; they have a significant impact on the choice of medical therapy of NSCLC. The use of targeted therapy with tyrosine kinase inhibitors requires performance of appropriate genetic tests in NSCLC patients. The aim of this study was to develop a real-time PCRbased diagnostic test-system for rapid and cost-effective analysis of EGFR mutations in paraffin blocks and plasma and to perform comparative estimation of diagnostic characteristics features of real-time wild type blocking PCR and digital PCR. The study included 156 patients with different degrees of lung adenocarcinoma differentiation. A simple and efficient real-time PCR-based method for detection of L858R activating mutation and del19 deletion in the EGFR gene in DNA isolated from paraffin blocks or blood has been developed. The test system for EGFR mutations has been validated using 411 samples of paraffin blocks. The proposed system demonstrated high efficiency for DNA testing from paraffin blocks: a concordance with results of testing by means a Therascreen® EGFR RGQ PCR Kit (Qiagen, Germany) was 100%. Applicability of this test system has been also demonstrated for detection of mutations in plasma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hirsch, F., Varella-Garcia, M., Cappuzzo, F., et al., Ann. Oncol., 2007, vol. 18, pp. 752–760.

    Article  CAS  Google Scholar 

  2. Tomizawa, Y., Iijima, H., Sunaga, N., et al., Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res., 2005, vol. 11, pp. 6816–6822.

    Article  CAS  Google Scholar 

  3. Emel’yanova, M.A., Amosenko, F.A., Sem’yanikhina, A.V., et al., Mol. Biologiya, 2015, vol. 49, pp. 617–627.

    Google Scholar 

  4. Shanazarov, N.A., Sabirov, A.Kh., and Sirotkina, S.M., 2009, Rossiskyi Bioterapevticheskyi Zhurnal, vol. 8, pp. 85–90.

    Google Scholar 

  5. Brewer, M.R., Yun, C.-H., Lai, D., et al., Proc. Natl. Acad. Sci. USA, 2013, vol. 110, pp. 604–638.

    Google Scholar 

  6. Kosaka, T., Yamaki, E., Mogi, A., and Kuwano, H., J. Biomed. Biotechnol., 2011, vol. 23, pp. 25–32.

    Google Scholar 

  7. Peng, L., Song, Z., and Jiao, S., OncoTargets Ther., 2015, vol. 8, pp. 905–910.

    CAS  Google Scholar 

  8. Jackman, D.M., Yeap, B.Y., Sequist, L.V., et al., Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res., 2006, vol. 12, pp. 3908–3914.

    Article  CAS  Google Scholar 

  9. Lynch, T.J., Bell, D.W., Sordella, R., et al., N. Engl. J. Med., 2004, vol. 350, pp. 2129–2139.

    Article  CAS  Google Scholar 

  10. Gazdar, A.F., Oncogene, 2009, vol. 28, suppl. 1, pp. 24–31.

    Article  Google Scholar 

  11. Politi, K. and Lynch, T., Clin. Cancer Res., 2012, vol. 18, pp. 1490–1492.

    Article  CAS  Google Scholar 

  12. Pallis, A.G., Fennell, D.A., Szutowicz, E., et al., Br. J. Cancer, 2011, vol. 105, pp. 1–8.

    Article  CAS  Google Scholar 

  13. Ikeda, T., Nakamura, Y., Yamaguchi, H., et al., Clin. Lung Cancer, 2012, vol. 13, pp. 369–374.

    Article  CAS  Google Scholar 

  14. Jones, S., Chen, W., Parmigiani, G., et al., Proc. Natl. Acad. Sci. USA, 2008, vol. 105, pp. 4283–4288.

    Article  CAS  Google Scholar 

  15. Bratman, S.V., Newman, A.M., Alizadeh, A.A., and Diehn, M., Expert Rev. Mol. Diagn., 2015, vol. 15, pp. 715–719.

    CAS  Google Scholar 

  16. Kapp, J.R., Diss, T., Spicer, J., et al., J. Clin. Pathol., 2014, vol. 68, pp. 111–118.

    Article  Google Scholar 

  17. Sharma, S.V., Bell, D.W., Settleman, J., and Haber, D.A., Nat. Rev. Cancer, 2007, vol. 7, pp. 169–181.

    Article  CAS  Google Scholar 

  18. Nagai, Y., Miyazawa, H., Huqun, et al., Cancer Res., 2005, vol. 65, pp. 7276–7282.

    Article  CAS  Google Scholar 

  19. Heitzer, E., Ulz, P., and Geigl, J.B., Clin. Chem., 2015, vol. 61, pp. 112–123.

    Article  CAS  Google Scholar 

  20. Emel’yanova, M.A., Mazurenko, N.N., Gagarin, I.M., et al., Vestnik Blokhin RONC RAMS, 2012, vol. 23, pp. 617–627.

    Google Scholar 

  21. Dominguez, P.L. and Kolodney, M.S., Oncogene, 2005, vol. 24, pp. 6830–6834.

    Article  CAS  Google Scholar 

  22. Hanahan, D. and Weinberg, R.A., Cell, 2000, vol. 100, pp. 57–70.

    Article  CAS  Google Scholar 

  23. Douillard, J.-Y., Shepherd, F.A., Hirsh, V., et al., J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol., 2010, vol. 28, pp. 744–752.

    Article  CAS  Google Scholar 

  24. Iressa® [http://www.lsgeotar.ru/pharma_tn/3891.html].

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O. I. Brovkina.

Additional information

Original Russian Text © O.I. Brovkina, M.G. Gordiev, A.N. Toropovskiy, D.S. Khodyrev, R.F. Enikeev, O.A. Gusev, L.H. Shigapova, A.G. Nikitin, 2017, published in Biomeditsinskaya Khimiya.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brovkina, O.I., Gordiev, M.G., Toropovskiy, A.N. et al. Determination of EGFR gene somatic mutations in tissues and plasma of patients with non-small cell lung cancer. Biochem. Moscow Suppl. Ser. B 11, 279–285 (2017). https://doi.org/10.1134/S1990750817030027

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1990750817030027

Keywords

Navigation